Post My Press Release

Free Press Release Distribution

Category: Hardware (Page 1 of 2)

Epoxy Resin Market Size is projected to reach 8.77 Billion USD By 2021

The Global Epoxy Resin Market size is projected to reach USD 8.77 Billion by 2021 from the estimated USD 6.31 Billion in 2015, registering a CAGR of 5.77% between 2016 and 2021. The key drivers of the market are increasing penetration of composites, emerging demand from developing countries, and revolutionary advancements in weight reduction and safety.

Request for PDF report:

Paints & coatings is the biggest application segment for the epoxy resin market

The paints & coatings segment is the largest application and is projected to remain the same in the overall epoxy resin market, in terms of volume, during the forecast period. Economic expansion in the developing countries of Asia-Pacific will increase the demand of epoxy resin for paints & coatings application in building & construction and automotive end-use industries.

Building & construction sector expected to be the dominant end-use industry for epoxy resin

Increase in employment, increase in public & private non-residential spending, and rise of green building construction are driving the epoxy resin market in the building & construction end-use industry. Though the growth of this sector has slowed down, it would still provide opportunities for the growth of the epoxy resin market.

Asia-Pacific estimated to be the largest market during forecast period

Asia-Pacific is the largest market for epoxy resin, both in terms of volume and value, followed by North America and Western Europe. China, the U.S., and Germany are the largest producers of epoxy resins the respective regions. Building & construction is the largest consumer of epoxy resins materials in Asia-Pacific. China and Japan have the largest shares of the Asia-Pacific epoxy resin market. The market in India is witnessing the highest growth rate.

Major manufacturers operational in Epoxy Resin Market are Olin Corporation (U.S.), Nan Ya Plastics Corporation (Taiwan), Huntsman Corporation (U.S.), Hexion Inc. (U.S.), Kukdo Chemical Co. Ltd. (South Korea), Chang Chung Plastics Co. Ltd. (Taiwan), Aditya Birla Chemicals (Thailand), the 3M Company (U.S.), BASF SE (Germany), and Sinopec Corporation (China Olin Corporation (U.S.).

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Epoxy Resin Market.

For more details read our blog:

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441

Talc Market worth 4.01 Billion USD by 2027 at a CAGR of 4.6%

The report “Talc Market by Deposit Type (Talc Carbonate, Talc Chlorite), End-Use Industry (Plastics, Pulp & Paper, Ceramics, Paints & Coatings, Cosmetics & Personal Care, Pharmaceuticals, Food), and Region (Europe, APAC, North America) – Global Forecast to 2027”, is projected to grow from USD 2.68 billion in 2018 to USD 4.01 billion by 2027, at a CAGR of 4.6% from 2018 to 2027. Increasing demand for talc from the automotive industry, rapid industrialization, increased disposable incomes of the middle-class populations of emerging economies, and increasing R&D activities for the development of new grades of talc are opportunities for the growth of the talc market.

Request for free Sample pages:

Browse 135 market data Tables and 28 Figures spread through 143 Pages and in-depth TOC on “Talc Market

Based on deposit type, the talc carbonate segment is estimated to account for the largest share of the talc market in 2018

Based on deposit type, the talc carbonate segment is estimated to account for the largest share of the talc market in 2018. Talc carbonate deposits are mainly composed of talc carbonate and traces of chlorite. Carbonate is primarily composed of magnesite (magnesium carbonate) or dolomite (magnesium and calcium carbonate).

Based on end-use industry, the plastics segment is estimated to be the largest segment of the talc market in 2018

Based on end-use industry, the plastics segment is estimated to be the largest segment of the talc market in 2018. Talc is used as a reinforcing filler in polypropylene and engineering thermoplastics for automotive parts, domestic applications, electrical & electronic components, and food packaging.

The talc market in the Asia Pacific is expected to witness the highest growth during the forecast period

Asia Pacific is the fastest-growing region for talc globally. The growth of the Asia Pacific talc market can be attributed to the increasing demand for talc-reinforced polypropylene from the automotive industry. Continuously increasing population and rapid industrialization are factors driving the growth of the Asia Pacific talc market. China is the largest consumer of talc in the Asia Pacific region.

Key players in the talc market include Imerys (France), Mondo Minerals (Netherlands), Minerals Technologies (US), IMI Fabi (Italy), Golcha Minerals (India), and Nippon Talc (Japan), among others.

Early buyers will receive 10% free customization on this report.

Don’t miss out on business opportunities in Talc Market.

Speak to Our Analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441

Immune Thrombocytopenia (ITP) Market

Immune Thrombocytopenia (ITP) Market Global Trends, Top Vendors, Share Analysis, Prediction Analysis, Business Aesthetics, and Global Industry Forecast to 2023

Market Highlights:

As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers.

ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ITP – intravenous   immune   globulin (IVIG), thrombopoietin receptor agonists, corticosteroids and immune-suppressing drugs. Though these treatment options have gained a healthy mileage, they come with certain degree of risk of side-effects. Nonetheless, increased focus towards innovation and R&D is likely to create new avenues for market players in the foreseeable future. 

Competition Landscape:

  • Dova Pharmaceuticals
  • Jiangsu Hengrui Pharmaceutical Co
  • Ligand Pharmaceuticals
  • Rigel Pharmaceuticals
  • Kyowa Hakko Kirin Co
  • Amgen Inc
  • Shire
  • F.Hoffmann-La Roche Ltd
  • Shionogi Inc. CSL Limited
  • Novartis

Browse Complete Report Details and TOC Exclusively

Segmental Analysis:

  • The report includes a thorough segmental analysis of the market on the basis of end-user, treatment, and type.
  • By end-user, the market has been segmented into specialty centers, hospitals and clinics, research and academic institutes and others. Currently, the hospitals & clinic segment accounts for more than one-third share of the market. During the forecast period, the segment is expected to record an impressive 6.22% CAGR.
  • By treatment, the market has been segmented into thrombopoietin receptor agonists, corticosteroids, intravenous immunoglobulins and others. In terms of value, the corticosteroids segment currently commands for close to 40% market share and is projected to surge at a CAGR of 5.57%.
  • Based on type, the market has been segmented into acute immune thrombocytopenia and chronic immune thrombocytopenia. The chronic immune thrombocytopenia segment currently accounts for over two-third market and is expected to highly profitable in 2018 and beyond. The segment is likely to reach a valuation of USD 2,036.9 Mn by the end of assessment period, exhibiting a CAGR of 5.94%. Approval of numerous targeted treatments coupled with the rising prevalence of ITP is proving the impetus on the segment’s growth.

Regional Analysis:

The market has been covered across regions such as Europe, Americas, the Middle East & Africa (MEA) and Asia Pacific (APAC). In 2017, the Americas segment accounted for the largest market share and trend is likely to continue beyond 2018. Some of the factors that are supporting the growth of the market in the region include rising prevalence of ITP in countries such as the US, Canada, Mexico and Brazil, high healthcare expenditure and favorable reimbursement policies. As per the National Organization of Rare Disorders (NORD), the incidence rate of Immune thrombocytopenia among Americans is 3.3 per 100,000 adults/year approx. Meanwhile, Europe and APAC currently hold the second and third spot respectively. Presence of advanced healthcare infrastructure and strong government support is supporting the growth of the market Europe. In Asia Pacific, the market has gained a healthy momentum in recent years owing to factors such as increase penetration of healthcare services, growing awareness and expanding patient pool. The market for ITP in APAC is expected to witness a strong growth over the next couple of years.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312 Email:

Global PC as a Service (PCaaS) Market: By Offering, Vertical and Geography with Forecast to 2024

Bharat Book Bureau Provides the Trending Market Research Report on “PC as a Service (PCaaS) Market by Offering (Hardware, Software, Services), Enterprise Type (SMEs, Large Enterprises), Vertical (IT & Telecommunications, Healthcare & Life Sciences, Education, BFSI, Government), and Geography – Global Forecast to 2024” under Hardware & Software Category. The report provides information on industry overview, market size, latest developments, industry trends, Key Manufacturers,global presence,device to communicate and their future prospects.

Inclination toward OPEX model rather than CAPEX model is expected to drive the overall growth of PC as a Service market

The PC as a Service (PCaaS) market is currently in the growth phase and is expected to grow tremendously in the near future. The PCaaS market is estimated to be valued at USD 15.9 billion in 2019 and is expected to reach USD 141.6 billion by 2024, at a CAGR of 54.9% between 2019 and 2024. Factors such inclination of businesses toward the OPEX model rather than the CAPEX model; superior benefits offered by PCaaS business model; and additional advantages of the PCaaS model, such as flexibility and scalability, are driving the market towards high growth. The restraining factor for PCaaS is lack of product differentiation.

Request a free sample copy of PC as a Service (PCaaS) Market Report @

Services segment to hold the largest share of PCaaS market during the forecast period
The PCaaS agreement includes a variety of support and maintenance services. The PCaaS service suite consists of a collection of PC lifecycle services, which include installation, deployment and integration, asset recovery services, and repair and maintenance services as per the end-user requirements. These services offered are flexible since they can be tailored and customized. Many PC OEMs are offering direct services as per the contract. Also, there are managed service providers, and value-added resellers (VARs) who have been partnering with different hardware manufacturers, and software vendors, and provide complete PCaaS solutions under their brand names.

Large enterprises to grow at a higher CAGR, during the forecast period
Organizations with more than 500 employees are considered as large enterprises. Reduction in IT support and procurement workload, option to acquire the latest technology faster, and reduction in the cost of PC deployment are the major reasons why large enterprises are opting PCaaS. Large enterprises have a huge network of IT devices. Moreover, maintenance of these devices has a lot of costs associated with it; many IT departments also lack the expertise to assess the latest workplace solutions for availability, scalability, security, and other organization-specific compliances. PCaaS offers the maintenance of hardware, software, and other related services at a fixed monthly price helping large organizations to save costs.

The PCaaS market in North America to hold the largest share during the forecast period
North America contributes significantly to the PCaaS market, and the market is expected to witness a higher growth rate in this region during the forecast period. North America has always been at the forefront of adopting new and innovative technologies, such as PCaaS solutions. The market in this region provides a suitable environment in terms of government regulations and compliance, for start-ups and SMEs. This region is home to some of the major PCaaS providers such as HP, Dell, Microsoft, and CompuCom. The service providers, ranging from small businesses to multinational companies, in this region, have extensive expertise in managing the IT infrastructure and maintaining the operations. The high demand for PCs in various industries is a dominant driving force substantiating the market growth in the region.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the PCaaS ecosystem.

Breakdown of primary participants’ profile:
• By Company Type: Tier 1 = 35%, Tier 2 = 45%, and Tier 3 = 20%
• By Designation: C-Level Executives = 40%, Directors = 35%, and Others = 25%
• By Region: North America = 40%, Europe = 20%, APAC = 30%, and RoW = 10%

Lenovo (Hong Kong), Hewlett-Packard (US), Dell Technologies (US), CompuCom Systems (US), Microsoft (US), Service IT Direct (Bizbang) (US), StarHub (Singapore), Telia (Sweden), Arrow Electronics (US), SHI International (US), Softcat (England), Computer System Australia (CSA) (Australia), PC Connection (US), Hemmersbach (Germany), ATEA Group (Norway), SYNNEX Corporation (US), Zones (US), CHG-MERIDIAN (Germany), Innova Technology Services (UK), Utopic Software (US), Intel Corporation (US), XMA LTD (England), Capgemini (France), RAM-Tech PC Solutions (US), Panasonic Corporation (Japan), and Computacentre (UK) are a few major players in the PCaaS market.

Research Coverage:
Offering, enterprise type, vertical, and geography are the segments covered in this report. It also gives a detailed view of the market across four main regions: North America, Europe, APAC, and RoW.

Reasons to Buy the Report:
• This report includes statistics pertaining to the PCaaS market in terms of the offering, enterprise type, vertical, and geography, along with their respective market sizes.
• Major drivers, restraints, opportunities, and challenges for the PCaaS market have been provided in detail in this report.
• The report includes illustrative segmentation, analysis, and forecast for the PCaaS market based on its segments and subsegments.

Browse our full report with Table of Contents:

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Industry Trends & Analysis, Forecasts & Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau

Tel: +91 22 27810772 / 27810773
Follow us on: TwitterFacebookLinkedIn

Caps & Closures Market expected to be worth 68.71 Billion USD by 2021, at a CAGR of 5.62%, from 2016–2021

[199 Pages report] MarketsandMarkets projects that the Caps & Closures Market size will grow from USD 49.78 Billion in 2015 to USD 68.71 Billion by 2021, at an estimated CAGR of 5.62%. The caps & closures market is expected to witness high growth as a result of the growing end-use industry such as beverage and healthcare as well as the rising concerns toward product quality and safety. Caps & closures seal the content within the container and allows appropriate dispense of the contents.

Request for free sample report:

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Caps & Closures Market, By Raw Material

7 Caps & Closures Market, By Type

8 Caps & Closures Market, By End-Use Industry

9 Caps & Closures Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

The market share of plastic is the largest as per raw material and is further projected to be the fastest-growing segment. This is closely followed by metal which has the second-highest growth rate. Plastic resin such as polypropylene (PP) and polyethylene (PE) are widely used with PP expected to be the fastest-growing subsegment. The other types of raw materials that are used for manufacturing caps & closures include wood, glass, paperboard, and rubber & elastomer.

Factors such as stringent regulations in the caps & closures industry as well as growing demand for the substitutes such as blister packs act as a restraint for the growth of the market. The global market for caps & closures is dominated by players such as RPC Group PLC (U.K.), Crown Holdings Incorporation (U.S.), Amcor Limited Plc (Australia), Rexam PLC (U.K.), Berry Plastics Corporation (U.S.), Silgan Holdings Inc. (U.S.), AptarGroup Incorporated (U.S.), and Guala Closures Group (Italy). These players adopted various strategies such as expansion, agreements, acquisitions, and new product developments to cater to the needs of the caps & closures market.

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Caps & Closures Market.

Read Our blog for more details:

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441

Global FAM20B Gene(XYLK Antibody) Market Projected to Deliver Greater Revenues during the Forecast Period until 2025

The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various trends prevailing across the FAM20B Gene(XYLK Antibody) market. This study is titled “Global FAM20B Gene(XYLK Antibody) Market Insights, Forecast to 2025”, which carefully examines several vital factors such as market share, market revenue, market dynamics and competitive scenario active in the target market for the period between 2019 and 2025.

Request for free Sample @

This report studies the global market size of FAM20B Gene(XYLK Antibody) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of FAM20B Gene(XYLK Antibody) in these regions.

This research report categorizes the global FAM20B Gene(XYLK Antibody) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

In 2017, the global FAM20B Gene(XYLK Antibody) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the FAM20B Gene(XYLK Antibody) market based on company, product type, application and key regions.

The various contributors involved in the value chain of FAM20B Gene(XYLK Antibody) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the FAM20B Gene(XYLK Antibody) include
Abbexa Ltd(UK)
Novus Biologicals(US)
Atlas Antibodies(SE)

Market Size Split by Type
Above 90%
Above 95%
Above 99%
Market Size Split by Application
Biopharmaceutical Companies
Bioscience Research Institutions

Market size split by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

In this study, the years considered to estimate the market size of FAM20B Gene(XYLK Antibody) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of FAM20B Gene(XYLK Antibody) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Browse Full Report with TOC@

Table of Contents

1 Study Coverage
1.1 FAM20B Gene(XYLK Antibody) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global FAM20B Gene(XYLK Antibody) Market Size Growth Rate by Type
1.4.2 Above 90%
1.4.3 Above 95%
1.4.4 Above 99%
1.4.5 Others
1.5 Market by Application
1.5.1 Global FAM20B Gene(XYLK Antibody) Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Companies
1.5.3 Hospitals
1.5.4 Bioscience Research Institutions
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global FAM20B Gene(XYLK Antibody) Market Size
2.1.1 Global FAM20B Gene(XYLK Antibody) Revenue 2016-2025
2.1.2 Global FAM20B Gene(XYLK Antibody) Sales 2016-2025
2.2 FAM20B Gene(XYLK Antibody) Growth Rate by Regions
2.2.1 Global FAM20B Gene(XYLK Antibody) Sales by Regions
2.2.2 Global FAM20B Gene(XYLK Antibody) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 FAM20B Gene(XYLK Antibody) Sales by Manufacturers
3.1.1 FAM20B Gene(XYLK Antibody) Sales by Manufacturers
3.1.2 FAM20B Gene(XYLK Antibody) Sales Market Share by Manufacturers
3.1.3 Global FAM20B Gene(XYLK Antibody) Market Concentration Ratio (CR5 and HHI)
3.2 FAM20B Gene(XYLK Antibody) Revenue by Manufacturers
3.2.1 FAM20B Gene(XYLK Antibody) Revenue by Manufacturers (2016-2018)
3.2.2 FAM20B Gene(XYLK Antibody) Revenue Share by Manufacturers (2016-2018)
3.3 FAM20B Gene(XYLK Antibody) Price by Manufacturers
3.4 FAM20B Gene(XYLK Antibody) Manufacturing Base Distribution, Product Types
3.4.1 FAM20B Gene(XYLK Antibody) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers FAM20B Gene(XYLK Antibody) Product Category
3.4.3 Date of International Manufacturers Enter into FAM20B Gene(XYLK Antibody) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans


Enquire about this Report –    

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharma market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at –

Digital Utility Market Value to reach $244.31 Billion by 2022

According to the new market research report Digital Utility Market by Network (Generation, Transmission and Distribution, and Retail), Technology (Hardware and Integrated Solutions (Cloud and Software, Services)), and Region (North America, Europe, and Asia-Pacific) – Global Forecast to 2022″, published by MarketsandMarkets™, Global digital utility market is projected to grow at a CAGR of 12.57%, from 2017 to 2022, to reach a market size of USD 244.31 billion by 2022. North American market held the largest share in 2016 followed by the markets in Europe and Asia-Pacific. However, by 2022, the market in Asia-Pacific is projected to gain the largest share. Digital utility market growth is driven by strict regulatory requirements for electric utilities, energy efficiency mandates demanding carbon emission reduction, and increase in the number of distributed and renewable power generation projects.

Don’t miss out on business opportunities in Digital Utility Market. Speak to Analyst and gain crucial industry insights that will help your business grow:

The digital utility market in Asia-Pacific is projected to grow at the fastest rate during the forecast period. Increasing investment in the electrical infrastructure and growing decentralized power generation will be driving the growth of the digital utility market in the region during the forecast period. The developing smart grid projects and investments in smart cities are also driving the digital utility market in Asia-Pacific.

Browse and in-depth TOC on “Digital Utility Market

63 – Tables

35 – Figures

144 – Pages

View more detailed TOC @

The growth of the transmission and distribution segment is primarily driven by aging infrastructure in the power utilities industry. New digital devices and communications and control systems improve the efficiency of assets and increase the ability of operators to monitor and manage electric transmission and distribution systems. This would ultimately create new revenue pockets for the digital utility market during the forecast period.

North America: The largest market for digital utility

The market in North America is currently the largest market for digital utility, closely followed by the European market. Rising investments in aging electrical infrastructure and increasing electricity demand are driving the digital utility market in the North America. The market in the U.S. is estimated to be the largest in the region, followed by the markets in Canada and Mexico, during the forecast period.

Download PDF Brochure @   

The leading players in the digital utility market includes Accenture plc (Ireland), Cap Gemini S.A. (France), Cognizant Technology Solutions Corporation (U.S.), General Electric Company (U.S.), Siemens AG (Germany), SAP SE (Germany), International Business Machines Corporation (U.S.), and Oracle Corporation (U.S.), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441


Radiation-Induced Myelosuppression Treatment Market By 2028 Region, Application, Driver, Trends & Forecasts

radiation induced myelosuppression treatment market

Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years.

Radiation therapy has been a significant part of cancer treatment and the consistently high success rate associated with radiotherapy is projected to further push demand for radiation-induced myelosuppression treatment worldwide.

A new market research study on global radiation-induced myelosuppression treatment forecasts steady growth for the market in the next few years. Future Market Insights projects a moderate, just-under 4% yearly growth outlook, in 2019 and ahead.

Nutropenia is foreseen to generate maximum demand for radiation-induced myelosuppression treatment, whereas injectables are identified to hold a substantial share in the total market value, based on the route of administration of radiation-induced myelosuppression treatment. Thrombocytopenia and anemia are likely to present lucrative opporunities for radiation-induced myelosuppression treatment providers.

Request Sample Report @ 

Report tracks key factors driving revenue growth of the market –

  • Increasing prevalence of cancers
  • Early diagnosis, promising improved chances of positive outcomes
  • Fostering R&D funds supporting cancer research
  • Strong product pipeline
  • Bolstering adoption of chemo-radiotherapy in cancer treatment

In the backdrop of patent expiry, a majority of market leaders are shifting their focus to the expansion of product pipeline of a wide range of innovative formulations, likely to shape the radiation-induced myelosuppression treatment landscape.

  • Myelo001 by Myelo Therapeutics GmbH recently received an FDA approval as an orphan drug to be used in the ARS (acute radiation syndrome) treatment.
  • Mylan NV and Pfizer Inc. also reveived FDA approvals for their recently launched biosimilars – Epogen and Neupogen, and Neulasta respectively.

Patent expiry of originator biologics formulations is creating investment opportunities in biosimilars production – for the operators in radiation-induced myelosuppression treatment landscape. As there is a considerable cost difference of around 20% between originator biologics and biosimilars, patients are inclined more towards an economical means of treatment, thereby fueling the scope of penetration of radiation-induced myelosuppression treatment in coming years.

Backed by a majority of established players housing strong bases across North America, especially the US, the report indicates a steady growth outlook for the radiation-induced myelosuppression treatment market in the region. North America will reportedly continue to account for over 65% share in the global market value.

New product launches currently mark the top developmental strategy adopted by leading companies competing in the radiation-induced myelosuppression treatment market. A majority of key players are also identified to focus on enhancing their geographical foothold in global radiation-induced myelosuppression treatment landscape.  The report in a distinct section covers some of the key competitors operating in radiation-induced myelosuppression treatment marketplace, emphasizing their financial as well as strategic profiles in depth.

Request to View TOC @

A few of the profiled companies include Pfizer Inc., Janssen Pharmaceutical NV, Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, and Partner Therapeutics, Inc.

In the highly consolidated competitive landscape of global radiation-induced myelosuppression treatment, the three top ranking companies, i.e. Janssen Pharmaceutical NV, Amgen Inc., and Teva Pharmaceutical Industries Ltd. dominate in terms of market value. These players continue to hold winning revenue shares in the radiation-induced myelosuppression treatment owing to strong global presence and a considerable number of new drug approvals. Established companies are entering strategic partnerships and collaborations with regional leaders, in an effort to achieve better penetration into regional markets.

Page 1 of 2

Powered by WordPress & Theme by Anders Norén